Surmodics, Inc. Business Finance Contracts & Agreements
40 Contracts & Agreements
- Credit Agreements (12 contracts)
- Exchange Agreements (2)
- Loan Agreements (1)
- Modification Agreements (6)
- Purchase Agreements (4)
- Security Agreements (2)
- Share Agreements (5)
- Shareholders Agreements (1)
- Stock Agreements (7)
- Credit, Security and Guaranty Agreement dated as of October 14, 2022 by and among Surmodics, Inc., Surmodics Shared Services, LLC, Surmodics Holdings, LLC, Surmodics Coatings,... (Filed With SEC on October 17, 2022)
- Second Amendment to Loan and Security Agreement dated as of March 7, 2022 by and among Surmodics, Inc., the other loan parties party thereto and Bridgewater Bank (Filed With SEC on March 7, 2022)
- First Amendment to Loan and Security Agreement dated as of July 2, 2021 by and among Surmodics, Inc., the other loan parties party thereto, and Bridgewater Bank (Filed With SEC on July 6, 2021)
- Put and Call Option Agreement by and among SurModics MD, LLC and the shareholders of Vetex Medical Limited named therein dated as of July 2, 2021 (excluding schedules and... (Filed With SEC on July 6, 2021)
- Share Purchase Agreement by and among Surmodics, Inc., SurModics MD, LLC, and the shareholders of Vetex Medical Limited named therein dated as of July 2, 2021 (excluding certain... (Filed With SEC on July 6, 2021)
- Loan and Security Agreement dated as of September 14, 2020 by and among Surmodics, Inc., Surmodics Shared Services, LLC, Surmodics Coatings, LLC, Surmodics Coatings Mfg, LLC,... (Filed With SEC on September 15, 2020)
- Form of Deferred Stock Unit Master Agreement (for non-employee directors) (Filed With SEC on May 6, 2019)
- Form of Restricted Stock Unit Award Agreement (for non-employee directors) (Filed With SEC on May 6, 2019)
- Form of Restricted Stock Unit Award Agreement (for employees) (Filed With SEC on May 6, 2019)
- Form of Restricted Stock Award Agreement (Filed With SEC on May 6, 2019)
- Form of Non-Qualified Stock Option Award Agreement (Filed With SEC on May 6, 2019)
- AMENDED AND RESTATED REVOLVING LINE OF CREDIT NOTE (Filed With SEC on November 7, 2016)
- Exhibit 10.1 AMENDED AND RESTATED CREDIT AGREEMENT (Filed With SEC on November 7, 2016)
- SixTH AMENDMENT TO CREDIT AGREEMENT (Filed With SEC on July 29, 2016)
- FIFTH AMENDMENT TO CREDIT AGREEMENT (Filed With SEC on July 29, 2016)
- FOURTH AMENDMENT TO CREDIT AGREEMENT (Filed With SEC on May 10, 2016)
- THIRD AMENDMENT TO CREDIT AGREEMENT (Filed With SEC on February 5, 2016)
- STOCK PURCHASE AGREEMENT AMONG SURMODICS, INC. (asBuyer) AND THE SHAREHOLDERS OF NORMEDIX, INC. (as Sellers) AND Gregg Sutton (as Sellers Agent) Dated as of January 8, 2016 TABLE... (Filed With SEC on January 13, 2016)
- SECOND AMENDMENT TO CREDIT AGREEMENT (Filed With SEC on November 27, 2015)
- DATED 20 NOVEMBER 2015 (1) THE SHAREHOLDERS OF CREAGH MEDICAL LIMITED (2) SURMODICS, INC. PUT AND CALL OPTION AGREEMENTRELATING TO SHARES IN CREAGH MEDICAL LIMITED LKG SOLICITORS... (Filed With SEC on November 27, 2015)
- SHARE PURCHASE AGREEMENT AMONG SURMODICS, INC. (as Buyer) AND THE SHAREHOLDERSOF CREAGH MEDICAL LIMITED (as Sellers) AND LKG SECRETARIALLIMITED (as Sellers Agent) Dated as of 20... (Filed With SEC on November 27, 2015)
- FIXED $$ DISCOUNTED SHARE BUYBACK (DSB) WITH INITIAL DELIVERY (Filed With SEC on December 5, 2014)
- FIRST AMENDMENT TO CREDIT AGREEMENT (Filed With SEC on November 6, 2014)
- REVOLVING LINE OF CREDIT NOTE (Filed With SEC on November 5, 2013)
- CREDIT AGREEMENT (Filed With SEC on November 5, 2013)
- ASSET PURCHASE AGREEMENT by and among Evonik Degussa Corporation as Purchaser, SurModics Pharmaceuticals, Inc. as Seller, and SurModics, Inc. as Stockholder DATED NOVEMBER 1, 2011... (Filed With SEC on November 7, 2011)
- in thousands, except share data (Filed With SEC on May 10, 2011)
- Medical Device, comprised of surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, as well as drug delivery... (Filed With SEC on December 14, 2010)
- SURMODICS, INC. 2009 EQUITY INCENTIVE PLAN Incentive Stock Option Agreement Full Name of Participant: Number of Shares Covered: Grant Date: Exercise Price Per Share: Expiration... (Filed With SEC on February 12, 2010)
- In thousands, except share data (Filed With SEC on February 5, 2010)
- In thousands, except share data (Filed With SEC on February 5, 2010)
- Cardiovascular, supporting the drug delivery and surface modification needs of our cardiovascular customers by providing drug delivery polymers and coating technologies including... (Filed With SEC on December 11, 2009)
- Cardiovascular, supporting the drug delivery and surface modification needs of our cardiovascular customers by providing drug delivery polymers and coating technologies including... (Filed With SEC on December 11, 2009)
- Cardiovascular, supporting the drug delivery and surface modification needs of our cardiovascular customers by providing drug delivery polymers and coating technologies including... (Filed With SEC on December 11, 2009)
- Cardiovascular, supporting the drug delivery and surface modification needs of our cardiovascular customers by providing drug delivery polymers and coating technologies including... (Filed With SEC on December 11, 2009)
- Cardiovascular, supporting the drug delivery and surface modification needs of our cardiovascular customers by providing drug delivery polymers and coating technologies including... (Filed With SEC on December 11, 2009)
- CREDIT AGREEMENT (Filed With SEC on March 4, 2009)
- Real Estate Purchase Agreement (Filed With SEC on May 9, 2008)
- Series C Preferred Purchase Agreement (Filed With SEC on February 14, 2002)
- Purchase Agreement (Filed With SEC on February 14, 2002)
